Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Income Statement 2016–2025
| Dec 2025 | Dec 2024 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -16.7M | -16.2M | -4.3M | -3.3M | -16.6M | -1.2M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -13.7M | -15.6M | -4.2M | -3.2M | -16.6M | -1.2M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 7M | 6M | 11M | 9M | 9M | 0M |
Monopar Therapeutics Inc. Income Statement — FAQ
Monopar Therapeutics Inc. (MNPR) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNPR's income statement history?
The chart and table above show Monopar Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.